Skip to content

Total debt at other companies

NeoGenomics logo
NeoGenomicsNEO
$66.29M+5.3%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$85.36M+49.8%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Labcorp Holdings logo
Labcorp HoldingsLH
Quest Diagnostics logo
Quest DiagnosticsDGX
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s total debt?
Fulgent Genetics, Inc. (FLGT) reported total debt of $8.21M in Q1 2026.
How has Fulgent Genetics, Inc.'s total debt changed year-over-year?
Fulgent Genetics, Inc.'s total debt increased by 40.5% year-over-year, from $5.85M to $8.21M.
What is the long-term trend for Fulgent Genetics, Inc.'s total debt?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s total debt has grown at a 46.3% compound annual growth rate (CAGR), from $835K to $5.6M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.